It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Mania, the diagnostic hallmark of bipolar disorder, is an episodic disturbance of mood, sleep, behavior, and perception. Improved understanding of the neurobiology of mania is expected to allow for novel avenues to address current challenges in its diagnosis and treatment. Previous research focusing on the impairment of functional neuronal circuits and brain networks has resulted in heterogenous findings, possibly due to a focus on bipolar disorder and its several phases, rather than on the unique context of mania. Here we present a comprehensive overview of the evidence regarding the functional neuroanatomy of mania. Our interpretation of the best available evidence is consistent with a convergent model of lateralized circuit dysfunction in mania, with hypoactivity of the ventral prefrontal cortex in the right hemisphere, and hyperactivity of the amygdala, basal ganglia, and anterior cingulate cortex in the left hemisphere of the brain. Clarification of dysfunctional neuroanatomic substrates of mania may contribute not only to improve understanding of the neurobiology of bipolar disorder overall, but also highlights potential avenues for new circuit-based therapeutic approaches in the treatment of mania.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Champalimaud Foundation, Champalimaud Research and Clinical Centre, Lisbon, Portugal (GRID:grid.421010.6) (ISNI:0000 0004 0453 9636); Universidade Nova de Lisboa, NOVA Medical School, NMS, Lisbon, Portugal (GRID:grid.10772.33) (ISNI:0000000121511713); Centro Hospitalar de Lisboa Ocidental, Departamento de Psiquiatria e Saúde Mental, Lisbon, Portugal (GRID:grid.418335.8) (ISNI:0000 0000 9104 7306)
2 Champalimaud Foundation, Champalimaud Research and Clinical Centre, Lisbon, Portugal (GRID:grid.421010.6) (ISNI:0000 0004 0453 9636); Universidade Nova de Lisboa, NOVA Medical School, NMS, Lisbon, Portugal (GRID:grid.10772.33) (ISNI:0000000121511713)